Patient violence and and antibiotic abuse: Evidence from China

Authors

  • Fuyong Lu University of International Business and Economics Institute of Education and Economy Research, Beijing, 100029, China Author

DOI:

https://doi.org/10.71222/nk1swe43

Keywords:

patient violence, antibiotics, China, decision-making

Abstract

Antibiotic abuse poses a critical public health challenge in China, with existing literature primarily emphasizing physicians' economic incentives as the driving force. This paper identifies a novel mechanism: patient violence as a catalyst for defensive antibiotic prescribing. Leveraging a violent incident at a top-tier Beijing hospital with a 95% patient satisfaction rating, we analyze over 67,000 electronic consultation records from an online platform where physicians' income derives solely from service fees-effectively isolating economic incentives from prescribing behavior. Using a difference-in-differences framework with physician and time fixed effects, we find that physicians in the affected department increase antibiotic prescriptions by 11.4 percentage points and non-prescription antibiotic guidance by 11.3 percentage points following the incident. These effects concentrate among patients expressing recovery expectations, with no significant impact on other patients, and decay within one week. Our findings reveal "appeasement behavior" as a distinct form of defensive medicine-physicians accommodate patient demands to mitigate conflict risk when clinical relationships become strained. The results underscore that antibiotic abuse is not solely an economic phenomenon but also a behavioral response to workplace violence, with important implications for antibiotic stewardship programs and patient safety policies.

References

1. J. Currie, W. Lin, and J. Meng, "Addressing antibiotic abuse in China: an experimental audit study," Journal of development economics, vol. 110, pp. 39-51, 2014. doi: 10.1016/j.jdeveco.2014.05.006

2. L. S. Roope, R. D. Smith, K. B. Pouwels, J. Buchanan, L. Abel, P. Eibich, and S. Wordsworth, "The challenge of antimicrobial resistance: what economics can contribute," Science, vol. 364, no. 6435, p. eaau4679, 2019.

3. C. Lopez, A. Sautmann, and S. Schaner, "Does patient demand contribute to the overuse of prescription drugs?," American Economic Journal: Applied Economics, vol. 14, no. 1, pp. 225-260, 2022. doi: 10.1257/app.20190722

4. Q. Huang, Z. Lu, and C. C. Zhuang, "Physician Agency and the ZeroMarkup Drug Policy in China: Evidence From a Structural Model," Health Economics, 2025. doi: 10.1002/hec.70073

5. N. Zhang, Y. Dong, Y. Li, and M. Guo, "Moral hazard in physician prescribing behavior: Evidence from China's zero-markup policy," Applied Economics, vol. 57, no. 58, pp. 9950-9963, 2025. doi: 10.1080/00036846.2024.2424502

6. J. Currie, W. Lin, and W. Zhang, "Patient knowledge and antibiotic abuse: Evidence from an audit study in China," Journal of health economics, vol. 30, no. 5, pp. 933-949, 2011. doi: 10.1016/j.jhealeco.2011.05.009

7. R. Agarwal, M. Dugas, and G. Gao, "Augmenting physicians with artificial intelligence to transform healthcare: Challenges and opportunities," Journal of Economics & Management Strategy, vol. 33, no. 2, pp. 360-374, 2024.

8. X. Zhao, X. Li, B. Torgler, and U. Dulleck, "Patient violence, physicians treatment decisions, and patient welfare: Evidence from China," Health economics, vol. 30, no. 6, pp. 1461-1479, 2021. doi: 10.1002/hec.4260

9. E. N. Okeke, "Playing defense? Health care in the era of Covid," Journal of Health Economics, vol. 85, p. 102665, 2022. doi: 10.1016/j.jhealeco.2022.102665

10. C. Ente, and M. Ukpe, "Essentials for quality and safety improvement in health care," Springer International Publishing, 2022.

Downloads

Published

04 March 2026

Issue

Section

Article

How to Cite

[1]
F. Lu , Tran., “Patient violence and and antibiotic abuse: Evidence from China”, Eur. J. Public Health Environ. Res., vol. 2, no. 1, pp. 21–28, Mar. 2026, doi: 10.71222/nk1swe43.